At-home medical devices are health hazards: More care delivery is moving into the home. Are health tech device makers and healthcare providers up to the task of keeping patients safe?
The No Surprises Act for medical bills is working—for the most part: Far fewer patients are getting hit with huge bills for out-of-network care, but providers and insurers are quarreling over payments.
Publicis Health pays for its role in fueling the opioid crisis: Ad agencies, you’ve been warned. It’s not just drugmakers that will be penalized for misleading physicians and patients about medications.
Digital health startups to watch: We spotlight pharma disruptor SmithRx and price transparency platform Turquoise Health on the back of fresh funding.
Fewer breaches, more compromised patient records: Cyber criminals are training their attacks on healthcare’s connected systems, often finding troves of patient data through third-party vendors.
More companies discontinue GLP-1 coverage: Drugmakers reaching sky-high valuations from selling GLP-1s may soon have to decide if it’s worth lowering the price of the meds.
Docs should be kept in the loop on genAI investments: Getting input from physicians on which AI models to deploy and for which clinical purposes will help secure buy-in.
Consumers use CTV for health-related searches: Connected TV watchers looked for fitness and mental health content in early January, per Roku data. That’s a trend healthcare and pharma marketers should jump on.
Buckle up for a gov’t probe, MA marketers: The Senate Finance Committee is ramping up an investigation into Medicare Advantage (MA) marketing practices among some third-party organizations. We don’t see this going away any time soon.
Digital health at CES 2024: AI in healthcare was showcased at CES 2024. We explore how marketers can capitalize on the trend.
Concerning cancer trends for 2024: Cancer rates are down overall, but don’t be misled. Cancer patients are getting younger and there are still overlooked populations getting sicker.
Physicians seek temp positions for better work-life balance: Healthcare employers still face staff shortages and rising labor costs. Physicians want better compensation and flexible work schedules. It’s time for both sides to talk.
Digital health startups to watch: We spotlight multispecialty care group Harbor Health and autism therapy company Forta on the back of fresh funding
Amazon Pharmacy and One Medical grow closer: We explore why Amazon wants its pharmacists more involved with patient care.
Employers demand lower drug costs: Tyson Foods is the latest large US employer to switch its drug benefits plan to an independent pharmacy benefit manager. 2024 could be a watershed year for the US prescription drug market.
Patients generally trust their local health system: They feel much differently about hospitals outside their communities. Here’s how healthcare marketers can use this information to their advantage.
Making the case for heart health: Heart disease is the leading cause of death in the US and it’s getting more costly for employers and health plans. But getting employees to sign on will take some effort.
Home internet use is rising for Medicare beneficiaries: But it’s still limited by socioeconomic factors like race, education, and income status. Here’s what providers and marketers should know about this growing audience.
General Catalyst will buy Summa Health: The VC firm plans to try out digital solutions with the Ohio-based health system. It could flop like Haven—or transform some aspects of the US healthcare system.
Medicare Advantage plans face a challenging year ahead: How might the various headwinds in front of MA insurers affect their businesses in 2024?